2017
DOI: 10.1002/lary.26827
|View full text |Cite
|
Sign up to set email alerts
|

Balloon dilation of the eustachian tube for dilatory dysfunction: A randomized controlled trial

Abstract: 1b. Laryngoscope, 128:1200-1206, 2018.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

12
164
1
7

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 119 publications
(185 citation statements)
references
References 26 publications
12
164
1
7
Order By: Relevance
“…New treatments for nonpatulous ETD, including balloon dilation, have generated renewed interest in the pathophysiology, treatment options, and prognosis for these patients. [5][6][7] Recent advances in diagnostic evaluation include a more rigorous evaluation and nuanced understanding of the eustachian tube orifice anatomy and dynamic function via nasal endoscopy, as well as more research-related diagnostic tests such as sonotubometry, tubomanometry, pressure chamber test, and inflation-deflation test. [8][9][10][11][12][13][14][15] The ETDQ-7 is a recently developed tool that more thoroughly and reproducibly evaluates ETD symptoms.…”
Section: Discussionmentioning
confidence: 99%
“…New treatments for nonpatulous ETD, including balloon dilation, have generated renewed interest in the pathophysiology, treatment options, and prognosis for these patients. [5][6][7] Recent advances in diagnostic evaluation include a more rigorous evaluation and nuanced understanding of the eustachian tube orifice anatomy and dynamic function via nasal endoscopy, as well as more research-related diagnostic tests such as sonotubometry, tubomanometry, pressure chamber test, and inflation-deflation test. [8][9][10][11][12][13][14][15] The ETDQ-7 is a recently developed tool that more thoroughly and reproducibly evaluates ETD symptoms.…”
Section: Discussionmentioning
confidence: 99%
“…The most notable improvement, aside from the patient's ability to return to symptom‐free diving operations, is the change in ETDQ‐7 scores from 5.6 (moderately severe symptoms) to 2.0, which is considered normal …”
Section: Discussionmentioning
confidence: 99%
“…Increased interest in the management of ET dysfunction (ETD) has reached a new level with the recent approval by the Food and Drug Administration of a new device for balloon dilation of the ET (BDET) in adults . Pediatric use of this intervention has been advocated at professional meetings, and children have already been receiving BDET treatment (off‐label in the United States) around the world for years .…”
Section: Introductionmentioning
confidence: 99%
“…13,14 Increased interest in the management of ET dysfunction (ETD) has reached a new level with the recent approval by the Food and Drug Administration of a new device for balloon dilation of the ET (BDET) in adults. 15 Pediatric use of this intervention has been advocated at professional meetings, and children have already been receiving BDET treatment (off-label in the United States) around the world for years. 16,17 This study discusses the clinical presentations, findings, and results of ETF tests in children evaluated for ETD at a specialty clinic and discusses the implications for BDET in this population.…”
Section: Introductionmentioning
confidence: 99%